Clinical Trial Update: Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 [Phase 3]

View source ↗

Summary

Phase 3 trial IBCSG-1-98 evaluating bone density and bone loss in postmenopausal women with breast cancer receiving treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer, Osteoporosis | Phase 3 | Status: COMPLETED